Gilead Sciences
Clinical trials sponsored by Gilead Sciences, explained in plain language.
-
Drug trial halted for skin lupus treatment
Disease control TerminatedThis study tested whether a drug called edecesertib (GS-5718) could safely reduce skin rashes and lesions in people with cutaneous lupus erythematosus (CLE), a condition where the immune system attacks the skin. The trial was small, involving 20 participants, and was designed to …
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Drug combo tested in fight against tough head and neck cancers
Disease control TerminatedThis study tested whether adding an experimental drug called magrolimab to other cancer therapies could help control advanced head and neck cancer. It involved 193 people whose cancer had spread or returned and could not be cured with surgery or radiation. The main goals were to …
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
First human test of new HIV pill halted after just 4 people
Disease control TerminatedThis was an early, small study to test the safety and initial effects of a new HIV medication called GS-1219. It involved only 4 people living with HIV who were not on other treatments. The main goals were to see how the drug moves through the body and if it can lower the amount …
Phase: PHASE1 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug combo tested against aggressive breast cancer
Disease control TerminatedThis study tested whether adding an experimental drug called magrolimab to standard chemotherapy could better control advanced triple-negative breast cancer. Researchers enrolled 92 patients with cancer that couldn't be surgically removed and had spread locally or to other body p…
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Feb 23, 2026 14:53 UTC